ISPO

Cancer Detection and Prevention Volume 17 / Issue 3 (May-Jun 1993)

Table of Contents and Editor's Notes

The peer review process occasionally results in approval of controversial publications that do not necessarily reflect the viewpoint of the editors. Readers of the journal are encouraged to critically review and comment on presented data by submitting a "Letter to the Editor" that may be reprinted in a subsequent issue.

Recruiting Older Women for Screening Mammography

Susan Halabi, M.P.H., Victor G. Vogel, M.D., M.H.S., Melissa L. Bondy, Ph.D., and Sally W. Vernon, Ph.D.

Barriers to Screening Among Participants of a Media-Promoted Breast Cancer Screening Project

Richard G. Roetzheim, M.D., Daniel J. Van Durme, M.D., Harrison J. Brownlee, M.D., Arthur H. Herold, M.D., Laurie J. Woodard, M.D., and Clifford Blair, Ph.D.

Relationship between Immunohistochemically Detectable p53 Protein and Prognostic Factors in Head and Neck Tumors*

Markus Gapany, M.D., Zlatko P. Pavelic, M.D., Ph.D., Sabina R. Gapany, B.S., Ljiljana Pavelic, B.A., Ya-qin Li, M.D., James M. Craven, M.D., Herbert Jones, M.D., Paul Biddinger, M.D., Peter J. Stambrook, Ph.D., and Jack L. Gluckman, M.D.

Cathepsin B and Cysteine Proteinase Inhibitors in Bronchoalveolar Lavage Fluid of Lung Cancer Patients

Kai Lüthgens, Ph.D., Werner Ebert, M.D., Ph.D., Günther Trefz, Ph.D., Dušica Gabrijelcic, Ph.D., Vito Turk, Ph.D., and Tamara Lah, Ph.D. Thoraxklinik Heidelberg-Rohrbach, D-W 6900, Heidelberg, Germany; MEDOR, Laboratorien für Biochemie und Klinische Chemie, D-W 8036 Herrsching, Germany: Josef Stefan Institute, 61000 Ljubljana, Slovenia; Department of Pathology, Metastasis Research Laboratory, Albert Einstein Medical Center, Philadelphia, PA 19141

Genomic Analysis of Human Hepatocellular Carcinomas Using Restriction Landmark Genomic Scanning

Hisaki Nagai, Shinji Hirotsune, Hideyuki Komatsubara, Izuho Hatada, Tsunehiro Mukai, Yoshihide Hayashizaki, and Kenichi Matsubara

The Putative Tumor Suppressor Gene on Chromosome 5q for Hepatocellular Carcinoma Is Distinct From the MCC and APC Genes

S.-F. Ding, M.D., J. D. A. Delhanty, Ph.D., J. S. Dooley, M.D., L. Bowles, B.Sc., C. B. Wood, M.D., and N. A. Habib, Ch.M.

Serum CEA, CA 15-3, and MCA in Breast Cancer Patients: A Clinical Evaluation

Lazzaro Repetto, Ph.D., Marina Onetto, B.Sc., Giovanni Gardin, M.D., Bruno Costanzi, Stefania Giudici, M.D., Elisabetta Vitiello, B.Sc., Laura Merlini, M.D., Cinzia Naso, M.D., Carla Zannini, B.Sc., Michela Paganuzzi, B.Sc., Riccardo Rosso, M.D., and Leonardo Santi, M.D.

The Value of Follow-Up after Curative Surgery of Colorectal Carcinoma

F. Safi, M.D. and H. G. Beyer, M.D.

Doxorubicin, Vincristine, and Actinomycin-D, But Not Teniposide, Require Long-Lasting Uninterrupted Verapamil Pressure to Overcome Drug Resistance in Multidrug-Resistant Cells

Giuseppe Toffoli, M.D., Loretta Tumiotto, Ph.D., Marco Gigante, M.D., Tiziana Perin, M.D., Gabriella Biscontin, and Mauro Boiocchi, Ph.D.

Cancer-Associated SCM-Recognition, Immunedefense Suppression, and Serine Protease Protection Peptide. Part II. Immunedefense Suppressive Effects of the CRISPPS Peptide

Lea Cercek, Ph.D. and Boris Cercek, D.Sc.

Cancer-Associated SCM-Recognition, Immunedefense Suppression, and Serine Protease Protection Peptide. Part III. CRISPP Peptide Protection of Serine Proteases Against Inhibition

Lea Cercek, Ph.D. and Boris Cercek, D.Sc.

 

Herbert E. Nieburgs, MD
Worcester, MA
1993